TSH Biopharm Salute del bilancio
Salute finanziaria criteri di controllo 6/6
TSH Biopharm has a total shareholder equity of NT$1.5B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.7B and NT$224.2M respectively. TSH Biopharm's EBIT is NT$118.3M making its interest coverage ratio -10.5. It has cash and short-term investments of NT$684.2M.
Informazioni chiave
0%
Rapporto debito/patrimonio netto
NT$0
Debito
| Indice di copertura degli interessi | -10.5x |
| Contanti | NT$684.18m |
| Patrimonio netto | NT$1.51b |
| Totale passività | NT$224.20m |
| Totale attività | NT$1.74b |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Analisi della posizione finanziaria
Passività a breve termine: 8432's short term assets (NT$1.2B) exceed its short term liabilities (NT$222.3M).
Passività a lungo termine: 8432's short term assets (NT$1.2B) exceed its long term liabilities (NT$1.9M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 8432 is debt free.
Riduzione del debito: 8432 had no debt 5 years ago.
Copertura del debito: 8432 has no debt, therefore it does not need to be covered by operating cash flow.
Copertura degli interessi: 8432 has no debt, therefore coverage of interest payments is not a concern.